[{"Assets_0_Q3_USD":277427000.0,"CommonStockSharesOutstanding_0_Q3_shares":41435000.0,"EarningsPerShareBasic_1_Q3_USD":0.54,"EarningsPerShareBasic_3_Q3_USD":1.87,"EarningsPerShareDiluted_1_Q3_USD":0.52,"EarningsPerShareDiluted_3_Q3_USD":1.81,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":30478000.0,"NetIncomeLoss_1_Q3_USD":21679000.0,"NetIncomeLoss_3_Q3_USD":76516000.0,"StockholdersEquity_0_Q3_USD":96463000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":41339000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":42194000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":40061000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":40839000.0,"Ticker":"AVDL","CIK":"1012477","name":"AVADEL PHARMACEUTICALS PLC","OfficialName":"Avadel Pharmaceuticals plc American Depositary Shares","form":"10-Q","period":"20170930","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"391383731.0","Country":"France","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20171109"}]